Physician profile
Tiffany Sierro
NPI 1033744016
$3,156.06
in general payments reported to CMS, 2019-2025
17 companies · $1,089 in 2025
The $1,089 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.81 · 2023: $863 · 2024: $1,111 · 2025: $1,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,063.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,023.84 | 2023-2025 | Rinvoq, Skyrizi |
| Genzyme Corporation | $557.67 | 2023-2025 | |
| Ucb, INC. | $288.42 | 2025 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.16 | 2023-2024 | Spevigo |
| Galderma Laboratories, L.P. | $169.80 | 2025 | Nemluvio, Aklief |
| Incyte Corporation | $150.91 | 2023-2025 | Opzelura |
| Amgen INC. | $145.46 | 2024 | Otezla |
| Janssen Biotech, INC. | $125.00 | 2023 | Tremfya |
| Blueprint Medicines Corporation | $123.26 | 2025 | Ayvakit |
| Arcutis Biotherapeutics, INC. | $117.76 | 2024 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $92.81 | 2022 | |
| Ani Pharmaceuticals, INC. | $32.92 | 2025 | Purified Cortrophin Gel |
| Almirall LLC | $23.83 | 2025 | Seysara |
| Journey Medical Corporation | $22.93 | 2025 | |
| Smith+Nephew, INC. | $20.90 | 2025 | Collagenase Santyl |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $18.74 | 2025 | Zelsuvmi |
| Botanix Sb INC | $14.65 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Sierro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.